Abstract 233
| 1994 | 1998 | |||
|---|---|---|---|---|
| Prevalence/ 1000 persons | Males | Females | Males | Females |
| Age standardised prevalence | 3.3 | 1.8 | 1.5 | 0.9 |
| Prevalence <65 years | 3.0 | 1.6 | 1.2 | 0.8 |
| Prevalence >65 years | 5.9 | 3.9 | 4.2 | 2.6 |
| % prescribed PPI | 52.1 | 51.6 | 73.3 | 73.2 |
| % prescribed H2 antagonist | 72.3 | 70.8 | 41.2 | 44.7 |